There was no improvement in overall survival.
Having a first-degree relative with colorectal polyps may increase a person’s risk of developing colorectal cancer, indicating that earlier screening is warranted.
Health-related quality of life tended to improve over time with pembrolizumab but not with chemotherapy.
Patients without comorbidities were less likely to undergo screening for colorectal cancer than patients with comorbidities.
The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.